by Jordana Choucair | Jul 14, 2022 | Opioid/Substance Use Disorders
A new study of fatal overdoses found that relaxing access to methadone did not lead to more deaths. In March 2020, the federal government told methadone clinics they could allow stable patients with opioid addiction to take their medicine at home unsupervised....
by Jordana Choucair | Jul 13, 2022 | Opioid/Substance Use Disorders
Teva Pharmaceutical Industries Ltd. and AbbVie Inc.’s Allergan unit will pay $34 million in cash and $20 million worth of overdose reversal drug Narcan to settle a federal lawsuit brought by San Francisco alleging that the drugmakers fueled the opioid surge,...
by Jordana Choucair | Jul 5, 2022 | Opioid/Substance Use Disorders
A federal judge on Monday ruled in favor of three major U.S. drug distributors in a landmark lawsuit that accused them of fueling the opioid crisis in Cabell County, West Virginia. The county and the city of Huntington argued that AmerisourceBergen Drug Co., Cardinal...
by Jordana Choucair | Jul 1, 2022 | Opioid/Substance Use Disorders
New documents published by the University of California at San Francisco and Johns Hopkins University show that McKinsey & Company found opportunities to boost opioid manufacturers’ sales amid the addiction crisis from 2004 to 2019. According to the...
by Jordana Choucair | Jul 1, 2022 | Opioid/Substance Use Disorders
The National Academy of Medicine (NAM) published a recap of a meeting held by two of its workgroups to examine challenges to fully integrating telehealth and virtual care for both pain management and substance use disorder (SUD). The first meeting of the four-part...
by Jordana Choucair | Jun 28, 2022 | Opioid/Substance Use Disorders
The Supreme Court ruled that prosecutors need to prove that doctors knowingly prescribed drugs in aberrant ways to win convictions against them for unlawful distribution of controlled medicines. The decision came in a case brought by two doctors who were sentenced to...
Recent Comments